By Research and Markets (http://www.researchandmarkets.com/research/69zxtx/global_bipolar) has announced the addition of the "Global Bipolar Disorder Pipeline Highlights - 2014" report to their offering.
The latest report Bipolar Disorder Pipeline Highlights - 2014, provides most up-to-date information on key pipeline molecules in the global bipolar disorder market. It covers emerging therapies for bipolar disorder in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides bipolar disorder pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides bipolar disorder pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
Company:
The report provides bipolar disorder pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which bipolar disorder pipeline products will be launched in the US and Ex-US till 2017.
Summary:
- Bipolar Disorder phase 3 clinical trial pipeline molecules
- Bipolar Disorder phase 2 clinical trial pipeline molecules
- Bipolar Disorder phase 1 clinical trial pipeline molecules
- Bipolar Disorder preclinical research pipeline molecules
- Bipolar Disorder discovery stage pipeline molecules
- Bipolar Disorder pipeline molecules short-term launch highlights
Key Topics Covered:
1. Bipolar Disorder Pipeline by Stages
2. Bipolar Disorder Pipeline by Drug Class
3. Bipolar Disorder Pipeline by Company
4. Bipolar Disorder Phase 3 Clinical Trial Insights
5. Bipolar Disorder Phase 2 Clinical Trial Insights
6. Bipolar Disorder Phase 1 Clinical Trial Insights
7. Bipolar Disorder Preclinical Research Insights
8. Bipolar Disorder Discovery Stage Insights
9. Appendix
10. Research Methodology
Tables
For more information visit http://www.researchandmarkets.com/research/69zxtx/global_bipolar
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals
